Chemical and Biological Engineering

Chris Loose '02, along with collaborator Joel Moxley '02, has been awarded the MIT Business Venture Robert P. Goldberg Grand Prize, for high technology projects targeting specific markets. The award was given for the startup company, SteriCoat Inc. SteriCoat has developed a coating technology targeting the billion dollar medical catheter market, which significantly reduces the incident of catheter associated infections by preventing the formation of bacterial "biofilms" and killing bacterial invaders. SteriCoat's application technology allows coating of devices of virtually any size, shape or material. Its initial target market is central venous catheters (CVC), which access the patient's bloodstream directly. For providers, it minimizes expenses associated with treating catheter related bloodstream infections, which cost $10K-50K per infection.

For more info see the MIT Slone article.